US FDA Approves First Pill for Postpartum Depression Treatment Washington: In a groundbreaking development, the US Food and Drug Administration (FDA) has granted approval for the use of Suranolone, the very first oral medication designed specifically for treating postpartum depression in women. Each pill, comprising 50 grams, is to be taken daily for a period […]

FDA Approves First Pill to Treat Postpartum Depression: Suranolone Shows Promise in Clinical Trials